Monitoring of hematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation (alloSCT) by dual-color FISH analysis of X and Y chromosomes

Leukemia Research

Volumn 27, Issue 11, 2003, Pages 993-998

  Turkiewicz, Dominik ^a   Gorczynska, Ewa ^a   Toporski, Jacek ^a   Kalwak, Krzysztof ^a   Rybka, Blanka ^a   Noworolska, Dorota ^a   Boguslawska Jaworska, Janina ^a   Chybicka, Alicja ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Allogeneic hematopoietic cell transplantation; FISH; Graft rejection; Hematopoietic chimerism; Immune therapy; Relapse

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETOPOSIDE; FLUDARABINE; LYMPHOCYTE ANTIBODY; MELPHALAN; METHOTREXATE; OKT 3; THIOTEPA; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ALLOGENEIC RESTRICTION; ARTICLE; BIOLOGICAL MONITORING; BLOOD ANALYSIS; BONE MARROW; CELL NUCLEUS; CHILD; CHIMERA; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; DONOR; DRUG RESPONSE; FLUORESCENCE IN SITU HYBRIDIZATION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOST CELL; HUMAN; IMMUNOTHERAPY; INTERPHASE; PRIORITY JOURNAL; RELAPSE; RISK ASSESSMENT; SEQUENCE ANALYSIS; SEX DIFFERENCE; T LYMPHOCYTE; X CHROMOSOME; Y CHROMOSOME;

EID: 0038691855     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(03)00077-8     Document Type: Article

References (18)

1. McCann S.R., Lawler M. Mixed chimerism: detection and significance following BMT. Bone Marrow Transplant. 11:1993;91.
2. Bader P., Holle W., Klingebiel T., Handgretinger R., Benda N., Schlegel P.et al. Mixed hematopoietic chimerism after allogeneic bone marrow transplantation: the impact of quantitative PCR analysis for prediction of relapse and graft rejection in children. Bone Marrow Transplant. 19:1997;697.
3. Bader P., Beck J., Frey A., Shlegel P.G., Hebarth H., Handgretinger R.et al. Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT. Bone Marrow Transplant. 21:1998;487.
4. Bader P., Stoll K., Huber S., Geiselhart A., Handgretinger R., Niemeyer C.et al. Characterization of lineage-specific chimaerism in patients with acute leukaemia and myelodysplastic syndrome after allogeneic stem cell transplantation before and after relapse. Br. J. Haematol. 108:2000;761.
5. Roux E., Helg C., Chapuis B., Jeannet M., Roosnek E. Evolution of mixed chimerism after allogeneic bone marrow transplantation as determined on granulocytes and mononuclear cells by the polymerase chain reaction. Blood. 79:1992;2775.
6. Bader P., Klingebiel T., Schaudt A., Theurer-Mainka U., Handgretinger R., Lang P.et al. Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed chimerism: a single center experience of 12 children. Leukemia. 13:1999;2079.
7. Klingebiel T., Niethammer D., Dietz K., Bader P. Progress in chimerism analysis in childhood malignancies - the dilemma of biostatistical considerations and ethical implications. Leukemia. 15:2001;1989.
8. Biondi A., Balduzzi A. Questions on chimerism analysis after stem cell transplantation. Leukemia. 15:2001;1995.
9. Feinstein L., Sandmaier B., Maloney D., McSweeney P.A., Maris M., Flowers C.et al. Non-myeloablative hematopoietic cell transplantation. Replacing high-dose cytotoxic therapy by the graft-versus-tumor effect. Ann. N. Y. Acad. Sci. 938:2001;328.
10. González M., López-Pérez R., García-Sanz R., Pérez-Simón J.A., San Miguel J.F. Debate round-table: comments concerning chimerism studies. Leukemia. 15:2001;1986.
11. Diez-Martin J.L., Llamas P., Gosalvez J., Lopez-Fernandez C., Polo N., de la Fuente M.S.et al. Conventional cytogenetics and FISH evaluation of chimerism after sex-mismatched bone marrow transplantation (BMT) and donor leukocyte infusion (DLI). Haematologica. 83:1998;408.
12. Briones J., Urbano-Ispizua A., Lawler M., Rozman C., Gardiner N., Marin P.et al. High frequency of donor chimerism after allogeneic transplantation of CD34+-selected peripheral blood cells. Exp. Hematol. 26:1998;415.
13. Miflin G., Stainer C.J., Carter G.I., Byrne J.L., Haynes A.P., Russel N.H. Comparative serial and quantitative measurements of chimaerism following unmanipulated allogeneic transplantation of peripheral blood stem cells and bone marrow. Br. J. Hematol. 107:1999;429.
14. van Leeuwen J.E., van Tol M.J., Joosten A.M., Wijnen J.T., Verweij P.J., Khan P.M.et al. Persistence of host-type hematopoiesis after allogeneic bone marrow transplantation for leukemia is significantly related to the recipient's age and/or the conditioning regimen, but it is not associated with an increased risk of relapse. Blood. 15(83):1994;3059.
15. Hernandez-Fuentes M.P., Baker R.J., Lechler R.I. The alloresponse. Rev. Immunogenet. 1:1999;282.
16. Kumar L. Leukemia: management of relapse after allogeneic bone marrow transplantation. J. Clin. Oncol. 12:1994;1710.
17. Lee J.H., Klein H.G. From leukocyte reduction to leukocyte transfusion: the immunological effects of transfused leukocytes. Baillieres Best Pract. Res. Clin. Haematol. 13:2000;585.
18. Zetterquist H., Mattsson J., Uzunel M., Näsman-Björk I., Svenberg P., Tammik L.et al. Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia. Bone Marrow Transplant. 25:2000;843.